Location:
dCas9-VP64

dCas9-VP64 Transcriptional Activator


Product Introduction

dCas9-VP64 is an artificial chimeric protein formed by fusing nuclease-dead Cas9 (dCas9) with the VP64 transcriptional activation domain, representing the core component of the first-generation CRISPR activation (CRISPRa) system. The dCas9 moiety of this protein carries the D10A and N863A double mutations, completely abolishing DNA cleavage activity while retaining the ability to precisely bind target DNA sequences guided by sgRNA. The VP64 activation domain consists of four tandem copies of the herpes simplex virus VP16 transcriptional activation domain. VP16 itself is a potent eukaryotic transcriptional activator capable of efficiently recruiting endogenous cellular transcriptional complexes.

When a specific sgRNA guides dCas9-VP64 to bind to the promoter region of a target gene, the VP64 domain recruits transcriptional machinery components such as the pre-initiation complex, histone acetyltransferases, and the Mediator complex. This promotes the assembly of RNA polymerase II and transcription initiation, thereby achieving transcriptional upregulation of the target gene. This system typically achieves basal gene activation levels of 2- to 5-fold, with activation efficiency influenced by factors such as target site selection, chromatin accessibility, and cell type. To overcome the limitations of single sgRNA activation efficiency, researchers often employ multi-sgRNA strategies—designing multiple sgRNAs targeting different regions of the same gene promoter to significantly enhance transcriptional activation through synergistic effects. Some optimized systems can even achieve hundreds-fold gene upregulation.

Product Specifications

Parameter

Specification

Source

Recombinant expression in E. coli

Molecular Weight

~172 kDa

Concentration

20 µM

PAM Sequence

5'-NGG-3'

Mutation Sites

D10A + N863A

Activation Domain

VP64

Purity

≥95% (SDS-PAGE)

Endotoxin

<1 EU/μg

Storage Buffer

50 mM Tris-HCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 50% Glycerol

10× Reaction Buffer

50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl₂, 100 μg/ml BSA, pH 7.9

Product Specifications

Specifications

Catalog Number

Concentration

Volume

100 pmol

GR100401

20 μM

5 μL

500 pmol

GR100402

20 μM

25 μL

2500 pmol

GR100403

20 μM

125 μL

Application Scenarios

Gene Transcriptional Activation: Upregulating endogenous gene expression.

Gain-of-Function Screening: Genome-wide CRISPRa screens.

Cellular Reprogramming: Activating pluripotency-related genes to promote cell fate conversion.

Epigenetics Research: Studying the impact of transcriptional activation on chromatin states.

Gene Function Studies: Serving as an alternative to cDNA overexpression for functional studies.

Drug Target Validation: Validating therapeutic strategies by activating potential target genes.

References

Gilbert LA, et al. (2013). CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell. 154(2):442-451.

Perez-Pinera P, et al. (2013). RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 10(10):973-976.

Chavez A, et al. (2015). Highly efficient Cas9-mediated transcriptional programming. Nat Methods. 12(4):326-328.

Ramu G, et al. (2018). Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption. Nucleic Acids Res. 46(12):e71.